Showing 541 - 560 results of 224,509 for search '(( a ((((laser decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a largest decrease ))', query time: 0.83s Refine Results
  1. 541
  2. 542
  3. 543
  4. 544
  5. 545
  6. 546
  7. 547
  8. 548

    Downregulation of activin A leads to a decrease in proliferation. by Andreia Bufalino (5664958)

    Published 2015
    “…(C) Follistatin at 100 ng/ml significantly blocked BrdU incorporation in SCC-9 ZsGreen LN-1 cells, but no effects on cell cycle distribution were observed (D). Knockdown of activin A significantly decreased proliferation (E), enhancing the number of cells at G0/G1 and reducing the number in the S phase of cell cycle (F). …”
  9. 549
  10. 550
  11. 551
  12. 552

    Rhodomyrtone decreases expression of inflammatory transcripts by TNF-α+IL-17A stimulated in skin organ cultures. by Julalak Chorachoo (5855852)

    Published 2018
    “…<p>Skin biopsies were pre-treated with 400 ng/ml rhodomyrtone 6 h before stimulation with 10 ng/ml TNF-α and 20 ng/ml IL-17A. Rhodomyrtone treatment decreases production of <i>DEFB4</i>, <i>IL1B</i>, <i>IL17C</i>, <i>IL36G</i>, <i>LCN2</i>, <i>PI3</i>, <i>S100A7</i>, and <i>S100A8</i> transcripts as measured by qRT-PCR at 72 h. …”
  13. 553

    Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality by Johannes Raffler (793347)

    Published 2015
    “…In contrast, for the <i>SLC5A11</i> locus, we found increased levels of <i>myo</i>-inositol in urine whereas mGWAS in blood reported decreased levels for the same genetic variant. …”
  14. 554
  15. 555
  16. 556
  17. 557

    Increased oxidative stress, viral load and decreased survivability of N2a following RIG-I ablation. by Arshed Nazmi (215284)

    Published 2011
    “…No statistically significant change in the viability of N2a post 24 h of JEV-infection was observed. However, RIG-I ablation resulted in significantly decreased viability compared to mock-infected as well as JEV-infected groups (D). …”
  18. 558
  19. 559
  20. 560